Skip to content

Medical emergency? What to do

Singapore nets US cancer experts in biomedics drive

3-RXPublished January 7, 20065 min read

Key points

  • When top U.S. scientists Neal Copeland and Nancy Jenkins arrive in Singapore to set up a new cancer research project, they will bring some extraordinary luggage: thousands and thousands of mice.
  • They are prominent researchers, very successful in the U.S.," said Alan Colman, the British scientist whose team cloned Dolly, the world's most famous sheep.
  • Scientists in the United States now face restrictions on government funding for stem cell research, shriveling grants, and curbs on commercial spin-offs from their work such as consulting and other fees, Copeland and Jenkins told Reuters in a telephone interview ahead of their departure for Singapore.
  • Copeland and Jenkins said they had been won over by Singapore's scientific freedom, deep pockets and interest in commercial applications, at a time when the U.S. government's National Cancer Institute in Maryland -- where they worked for 20 years -- began a clamp down on consulting work by its scientists.

When top U.S. scientists Neal Copeland and Nancy Jenkins arrive in Singapore to set up a new cancer research project, they will bring some extraordinary luggage: thousands and thousands of mice.

The husband-and-wife team will bring 50 to 100 different strains of mice for their research into the most common types of human cancer when they move to the city-state in coming weeks. Their decision to relocate to Singapore -- which they chose over leading U.S. cancer research centers at New York's Memorial Sloan-Kettering and California's Stanford University -- is a coup for Singapore, where the government is spending billions of dollars to develop its biomedical industry.

"They are a big catch. They are prominent researchers, very successful in the U.S.," said Alan Colman, the British scientist whose team cloned Dolly, the world's most famous sheep.

Colman himself is one of a cluster of star scientists that Singapore has lured in a bid to put the city-state of 4.4 million people on the map for biomedical research and drugs production.

Scientists in the United States now face restrictions on government funding for stem cell research, shriveling grants, and curbs on commercial spin-offs from their work such as consulting and other fees, Copeland and Jenkins told Reuters in a telephone interview ahead of their departure for Singapore.

"The amount of money going toward research is going down. It doesn't have a high priority (in the United States). In Singapore it does," said Copeland, adding that they would like to exploit some of their Singapore-funded research commercially.

Copeland and Jenkins said they had been won over by Singapore's scientific freedom, deep pockets and interest in commercial applications, at a time when the U.S. government's National Cancer Institute in Maryland -- where they worked for 20 years -- began a clamp down on consulting work by its scientists.

"This is a chance to explore new areas," said Jenkins.

OF MICE AND MEN

Copeland, 58, and Jenkins, 55, use the mouse genome to study which genes trigger cancers in humans.

"We use mouse genetics as a tool for human diseases," Copeland said, adding that their research tries to identify the genes and develop the drugs to fight the most common cancers.

Copeland and Jenkins met 25 years ago as researchers at Harvard Medical School, and have worked together for more than 20 years, co-authoring over 700 research papers.

Their most recent work employs a technique known as "sleeping beauty" because of the way that it uses inactive genetic material to activate or awaken cancer genes.

That work could lead to a better understanding of the series of steps that take place when a person develops cancer, said David Lane, who heads the Institute of Molecular and Cell Biology in Singapore where Copeland and Jenkins will work.

Lane, who discovered the important "p53" cancer gene which suppresses tumors and whose work in Singapore focuses on zebra fish, said that with the arrival of Copeland and Jenkins, Singapore is starting to attract more interest in the scientific community as it has built up a critical mass of superstars.

"People will go to where the big names are," Lane said. "The challenge is to create a place where people want to come."

Philip Yeo, head of Singapore's Economic Development Board, makes no secret of the fact he wants to attract "whales" -- or scientists with an international reputation.

In addition to Colman, Singapore has attracted Sydney Brenner, co-winner of the 2002 Nobel prize in Physiology or Medicine for work on the genetic regulation of organ development.

Others include breast cancer researcher Edison Liu, who was born in Hong Kong and emigrated to the United States, and Japan's Yoshiaki Ito. Both had worked at the National Cancer Institute, and Ito was instrumental in enticing Copeland and Jenkins to Singapore.

MONEY AND ETHICS

In an era where funding is critical -- even a microscope can cost half a million dollars -- wealthy Singapore has the money.

That, say scientists, has been Singapore's attraction, along with speedy grant approvals and lack of burdensome paperwork.

"We don't want to spend the rest of our lives writing grants," said Copeland, adding that Singapore's quick access to funding was key. The couple's colony of 20,000 mice costs some $1 million a year to maintain.

Scientific research today is increasingly about access to grants and rewards such as fame, prizes and commercial spin-offs -- incentives which can sometimes lead to unethical practices, as South Korea's stem cell research scandal has shown.

But Copeland and Jenkins, who hope to be based in Singapore for the long run, say the fall-out will have no impact on Singapore's ambitions to become Asia's leading biomedical center.

Lane says Singapore already has a pile of applicants.

"You suddenly cross some threshold, where instead of scouring the world trying to get people to come here, you are suddenly in a position" to pick and choose, Lane said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancer

Keep reading

Brain

Italy court ruling links mobile phone use to tumor

Italy's supreme court has upheld a ruling that said there was a link between a business executive's brain tumor and his heavy mobile phone usage, potentially opening the door to further legal claims. The court's…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.